Michael Lauzardo, M.D., deputy director of UF’s Emerging Pathogens Institute and an associate professor in the UF College of Medicine’s department of medicine, talks about issues related to the third vaccine dose.
When a patient suffers a stroke, oxygen-starved brain cells begin dying within minutes. In these crucial moments, the brain produces a vital catalyst to protect itself and aid in recovery. That catalyst — an enzyme known as neurolysin — activates a cascade of chemical messengers that reduce cell damage, swelling and inflammation in the brain. Now, a University of Florida Health researcher and his collaborators at Texas Tech University and other universities have discovered two compounds that appear to make the brain-protecting enzyme even more effective.
People who have recovered from a bout of severe COVID-19 may still have a reason for concern about their health. A new University of Florida study has found that patients who had a severe case of the disease were more than twice as likely as patients who had mild or moderate COVID-19 to need hospitalization again for health problems caused by COVID-19 complications.